Madrigal Pharmaceuticals Aktie
311,40
EUR
-14,00
EUR
-4,30
%
327,56
USD
-12,71
USD
-3,74
%
Werbung
Madrigal Pharmaceuticals Aktie Analyse
10.06.19 | Madrigal Pharmaceuticals Buy | B. Riley FBR | |
28.02.19 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
14.12.18 | Madrigal Pharmaceuticals Outperform | Wolfe Research | |
12.12.18 | Madrigal Pharmaceuticals Neutral | B. Riley FBR | |
01.06.18 | Madrigal Pharmaceuticals Outperform | Oppenheimer & Co. Inc. | |
01.06.18 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
30.01.18 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
06.12.17 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. | |
Werbung
|
|||
29.11.17 | Madrigal Pharmaceuticals Buy | H.C. Wainwright & Co. |
Werbung
Werbung